Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients

Clinical trial NCT01601119 · COMPLETED

Trial details

NCT number: NCT01601119
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2012-01-01
Primary completion: 2014-07-01
Enrollment: 545

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.